Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gildan Activewear (GIL) Liabilities and Shareholders Equity (2017 - 2025)

Gildan Activewear (GIL) has disclosed Liabilities and Shareholders Equity for 8 consecutive years, with $10.5 billion as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 181.69% to $10.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.1 billion through Dec 2025, up 53.08% year-over-year, with the annual reading at $10.5 billion for FY2025, 181.69% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $10.5 billion at Gildan Activewear, up from $3.7 billion in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $10.5 billion in Q4 2025, with the low at $3.0 billion in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $4.5 billion, with a median of $3.5 billion recorded in 2023.
  • The sharpest move saw Liabilities and Shareholders Equity fell 5.92% in 2021, then soared 181.69% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $3.0 billion in 2021, then increased by 3.83% to $3.1 billion in 2022, then grew by 12.06% to $3.5 billion in 2023, then grew by 5.7% to $3.7 billion in 2024, then surged by 181.69% to $10.5 billion in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $10.5 billion, $3.7 billion, and $3.5 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.